John Nosenzo, Chief Commercial Officer at Bioventus Inc. (BVS), sold 131,926 shares at $11.12 ($1.5M) on 2022-04-04, disclosed to the SEC on 2022-04-05.
Open-market sale of $1.5M BVS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.12 | 65,963 | $734K | 50.0% |
| 2 | $11.12 | 65,963 | $734K | 50.0% |
| Total | $11.12 avg | 131,926 | $1.5M | 100% |
| Filing → |
| BVS | BUY | 2021-04-05 | $7K | — | Filing → |